SI0689841T1 - Powder preparation for healing damaged skin - Google Patents

Powder preparation for healing damaged skin

Info

Publication number
SI0689841T1
SI0689841T1 SI9530639T SI9530639T SI0689841T1 SI 0689841 T1 SI0689841 T1 SI 0689841T1 SI 9530639 T SI9530639 T SI 9530639T SI 9530639 T SI9530639 T SI 9530639T SI 0689841 T1 SI0689841 T1 SI 0689841T1
Authority
SI
Slovenia
Prior art keywords
powder preparation
damaged skin
healing damaged
salts
healing
Prior art date
Application number
SI9530639T
Other languages
English (en)
Slovenian (sl)
Inventor
Toshio Inagi
Saibi Suehiro
Original Assignee
Kowa Company, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Company, Ltd. filed Critical Kowa Company, Ltd.
Publication of SI0689841T1 publication Critical patent/SI0689841T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
SI9530639T 1994-06-27 1995-06-09 Powder preparation for healing damaged skin SI0689841T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP14439394A JP3583166B2 (ja) 1994-06-27 1994-06-27 損傷皮膚修復用粉末製剤
EP95108920A EP0689841B1 (en) 1994-06-27 1995-06-09 Powder preparation for healing damaged skin

Publications (1)

Publication Number Publication Date
SI0689841T1 true SI0689841T1 (en) 2003-04-30

Family

ID=15361113

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9530639T SI0689841T1 (en) 1994-06-27 1995-06-09 Powder preparation for healing damaged skin

Country Status (12)

Country Link
US (1) US5618799A (zh)
EP (1) EP0689841B1 (zh)
JP (1) JP3583166B2 (zh)
KR (1) KR100370313B1 (zh)
CN (1) CN1059088C (zh)
AT (1) ATE230270T1 (zh)
CA (1) CA2150888A1 (zh)
DE (1) DE69529249T2 (zh)
DK (1) DK0689841T3 (zh)
ES (1) ES2189811T3 (zh)
SI (1) SI0689841T1 (zh)
TW (1) TW336173B (zh)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU722246B2 (en) * 1995-06-07 2000-07-27 Johnson & Johnson Consumer Products, Inc. Stable complexes of crosslinked polyvinylpyrrolidone and iodine and method of making the same
US6562885B1 (en) 1998-03-19 2003-05-13 Battelle Memorial Institute Composition for deactivating chemically and biologically active agents and method of making the same
ATE246522T1 (de) 1998-06-19 2003-08-15 Oxibio Inc Implantierbare medizinische vorrichtung mit antiinfektiösen und kontrazeptiven eigenschaften
US6414223B1 (en) * 1998-08-03 2002-07-02 Cargill, Incorporated Plants, seeds and oils having an elevated total monounsaturated fatty acid content
ATE386554T1 (de) 1999-02-26 2008-03-15 Johnson & Johnson Consumer Bioadhesive antibakterielle wundheilungszusammensetzungen
JP2001122790A (ja) * 1999-10-22 2001-05-08 Mikasa Seiyaku Co Ltd 安定な褥瘡・皮膚潰瘍および創傷治療用製剤
CA2480889C (en) 2002-03-14 2011-11-15 Medrx Co., Ltd. External preparation for wounds
JP4712380B2 (ja) * 2002-07-26 2011-06-29 三笠製薬株式会社 外用剤
AU2003277640A1 (en) * 2002-11-11 2004-06-03 Kowa Co., Ltd. Composition for restoring damaged skin
US20040101507A1 (en) * 2002-11-27 2004-05-27 Janco Predovan Skin cream
WO2004056339A1 (de) * 2002-12-19 2004-07-08 Beisel Guenther Verfahren zur herstellung von mitteln zur oralen einnahme und entsprechende zusammensetzungen unter verwendung von polymeren und deren beschichtung mit hydrophilen flüssigkeiten
RU2245723C1 (ru) * 2003-07-24 2005-02-10 Вилесов Александр Дмитриевич Средство и способ лечения гнойно-воспалительных заболеваний мягких тканей
JP4575881B2 (ja) * 2003-09-22 2010-11-04 興和株式会社 損傷皮膚修復用貼付剤
US7673841B2 (en) 2004-03-25 2010-03-09 Cooper Technologies Company Hangar bar for recessed luminaires with integral nail
JP4575706B2 (ja) * 2004-04-23 2010-11-04 興和株式会社 損傷皮膚修復用組成物
JP4575705B2 (ja) * 2004-04-23 2010-11-04 興和株式会社 損傷皮膚修復用組成物
US7334538B1 (en) * 2004-07-27 2008-02-26 Aquascience Research Group, Inc. Topical medicants for aquatic animals
CN1279917C (zh) * 2004-09-09 2006-10-18 吕益明 一种创伤药及其制备方法和使用方法
CA2607419C (en) 2005-04-26 2014-06-17 Dainippon Sumitomo Pharma Co., Ltd. Granular preparation containing biguanide compound
NZ542258A (en) * 2005-09-06 2010-05-28 Comvita New Zealand Ltd A medical composition comprising honey or sugar syrup and a viscosity increasing agent for use on wounds
US8664295B2 (en) * 2005-10-28 2014-03-04 Nutripol Capital Sarl Polymeric compound, method of preparing a polymeric compound, use of a polymeric compound
EP2095812A4 (en) 2006-10-25 2011-07-13 Dainippon Sumitomo Pharma Co NON-AGGLUTINANT GRANULAR PREPARATION
JP5289975B2 (ja) * 2006-12-07 2013-09-11 第一三共株式会社 マンニトール又は乳糖を含有する固形製剤
EP2100606A4 (en) * 2006-12-07 2009-12-30 Daiichi Sankyo Co Ltd COATED PREPARATION OF A FILM HAVING IMPROVED STABILITY
US20100280064A1 (en) * 2006-12-07 2010-11-04 Tomoyuki Watanabe Pharmaceutical composition having improved storage stability
WO2008072535A1 (ja) 2006-12-07 2008-06-19 Daiichi Sankyo Company, Limited 低置換度ヒドロキシプロピルセルロースを含有する医薬組成物
BRPI0918827A2 (pt) * 2008-09-22 2015-12-08 Triosyn Holding Inc produto e processo de fabricação de resina iodada
CN101654499B (zh) * 2009-09-02 2011-08-31 陈煜� 天然高分子或其水溶性衍生物的两亲性接枝共聚物与纳米碘复合物及其制备方法
CN102846776B (zh) * 2012-09-28 2015-02-11 刘艳 一种由桃树末制成的药剂
WO2016109344A1 (en) * 2014-12-30 2016-07-07 3M Innovative Properties Company Bactericidal composition
CA2973725A1 (en) * 2015-01-20 2016-07-28 Veloce Biopharma Llc Novel iodophor composition and methods of use
EP4340848A1 (en) * 2021-05-18 2024-03-27 Povinez LLC Nasal antiseptic

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2353297A1 (fr) * 1976-01-26 1977-12-30 Tissier Gerard Nouveaux complexes neutres et insolubles de la polyvinylpolypyrrolidone et des halogenes, leurs procedes d'obtention et leurs applications
US4094967A (en) * 1976-10-22 1978-06-13 Allor Foundation Iodine-polyvinylpyrrolidone solid product and method of preparation
AU536885B2 (en) * 1979-04-18 1984-05-31 R. A. Knutson Wound and burn dressing
DE3312431A1 (de) * 1983-04-07 1984-10-11 B. Braun Melsungen Ag, 3508 Melsungen Pvp-iod-wundpuder mit synergistisch wirkender pudergrundlage
NL8500774A (nl) * 1985-03-18 1986-10-16 Dagra Nv Werkwijze ter bereiding van een vrij vloeiend, homogeen povidonjood wondpoeder.
CA1287584C (en) * 1986-09-02 1991-08-13 Seiichi Komori Wound-healing preparations
GB8622012D0 (en) * 1986-09-12 1986-10-22 Euro Celtique Sa Solid iodophor composition
CH678697A5 (zh) * 1989-04-03 1991-10-31 Warner Lambert Co
US4877927A (en) * 1989-04-06 1989-10-31 Hamlin Incorporated Extended dwell shock sensing device

Also Published As

Publication number Publication date
CA2150888A1 (en) 1995-12-28
ES2189811T3 (es) 2003-07-16
US5618799A (en) 1997-04-08
EP0689841B1 (en) 2003-01-02
DK0689841T3 (da) 2003-02-24
KR100370313B1 (ko) 2003-03-19
CN1059088C (zh) 2000-12-06
KR960000214A (ko) 1996-01-25
DE69529249T2 (de) 2003-08-07
JPH0812582A (ja) 1996-01-16
ATE230270T1 (de) 2003-01-15
CN1124143A (zh) 1996-06-12
JP3583166B2 (ja) 2004-10-27
DE69529249D1 (de) 2003-02-06
TW336173B (en) 1998-07-11
EP0689841A1 (en) 1996-01-03

Similar Documents

Publication Publication Date Title
SI0689841T1 (en) Powder preparation for healing damaged skin
EP0992501A3 (en) Pyridonecarboxylic acid derivatives as antibacterial agents
CA2356310A1 (en) External preparations containing a basic drug
CA2160182A1 (en) Antimicrobial adhesive composition for dental uses
NZ502445A (en) Control of acidic gut syndrome
TW229217B (zh)
CA2209060A1 (en) Water-soluble or water-swellable polymers
CA2227901A1 (en) Improved cement admixture product
AU6818196A (en) Substituted 2,4-imidazolidinedione compounds as pharmaceutical active ingredients
EP0369262A3 (en) Novel pyrroles
CA2068824A1 (en) Aqueous dispersions of sulfonylurea derivatives
WO2004060273A3 (en) Skin care composition containing an anionic polymer
ATE226450T1 (de) Gepufferte orthoesterpolymere enthaltende arzneimittel
MX9801967A (es) Tetrahidroquinolinas como antagonistas de los aminoacidos excitadores (nmda).
CA2152998A1 (en) Anti-hyperglycemia pharmaceutical composition
CA2254533A1 (en) Treatment of pruritus
FR2681777B1 (fr) Clou chirurgical implantable dans l'os.
EE03514B1 (et) Ühendite kombinatsioon HIV infektsiooni või AIDS-i raviks, selle kasutamine ja farmatseutiline kompositsioon
CA2379821A1 (en) Mixture for the treatment of waste materials
AU4585993A (en) Use of angiotensin ii antagonists for the treatment of hyperlipidaeme
AU5260096A (en) Novel pyridonecarboxylic acid derivatives or salts thereof and antibacterial agent containing the same as active ingredient
CA2385867A1 (en) Sustained release form comprising alpha-lipoic acid or derivatives thereof
AU6670596A (en) Remedies for anxiety neurosis
DK0605381T3 (da) Polymerforbindelse, især til medicinske anvendelser
CA2152373A1 (en) Treatment of cytomegalovirus infection